BlackRock
ICVX

BlackRock’s Icosavax, Inc. Common Stock ICVX Stock Holding History

BlackRock’s Portfolio ICVX Stock Details ICVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,581,530
Closed -$40.7M – 5456
2023
Q4 		$40.7M Buy
2,581,530
+585,250
+29% +$5.64M ﹤0.01% 2608
2023
Q3 		$15.5M Buy
1,996,280
+210,140
+12% +$1.74M ﹤0.01% 3082
2023
Q2 		$17.7M Buy
1,786,140
+475,777
+36% +$3.81M ﹤0.01% 3114
2023
Q1 		$7.6M Sell
1,310,363
-56,929
-4% -$492K ﹤0.01% 3460
2022
Q4 		$10.9M Sell
1,367,292
-145,556
-10% -$625K ﹤0.01% 3360
2022
Q3 		$4.78M Sell
1,512,848
-23,961
-2% -$150K ﹤0.01% 3772
2022
Q2 		$8.81M Buy
1,536,809
+24,183
+2% +$189K ﹤0.01% 3569
2022
Q1 		$10.7M Sell
1,512,626
-101,752
-6% -$1.6M ﹤0.01% 3547
2021
Q4 		$36.9M Buy
1,614,378
+37,008
+2% +$956K ﹤0.01% 2874
2021
Q3 		$46.7M Buy
+1,577,370
New +$53.5M ﹤0.01% 2703

BlackRock's ICVX Position: Q1 2024 in Review

BlackRock sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 2,581,530 shares — an estimated $40.7M sold.

BlackRock first reported a position in ICVX in Q3 2021 and held it in 10 quarters. The position peaked at $46.7M in Q3 2021. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

  • BlackRock reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • BlackRock sold 2,581,530 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $40.7M.
  • BlackRock first reported a position in Icosavax, Inc. Common Stock in Q3 2021 and held it in 10 quarters.
  • BlackRock's Icosavax, Inc. Common Stock position peaked at $46.7M in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on BlackRock's 13F filing for Q1 2024, filed 10 May 2024.